Laboratory of Pharmacogenomics

About us

Laboratory of Pharmacogenomics is involved in the study and development of prognostic and predictive biomarkers for more refined evaluation of survival of cancer patients and the response of tumor cells to the therapy. Genomic, epigenomic, proteomic, and metabolomic analyses of tissue preparations from cancer patients provided by clinical collaborators from the Czech Republic are performed for this purpose. Predictive biomarkers may help clinicians in the stratification of patients into different therapeutic regimens. Discovery and validation of prognostic biomarkers may also contribute to the invention of drugs for targeted therapy. Our team has experience in this area for more than 20 years. Research activities are supported by a number of grants including Center of Excellence awarded by Czech Science Foundation (see Projects). Lab members regularly publish our results in publicly accessible scientific journals (see Publications) and collaborate with several highly respected foreign partners (see Collaborations).

Releated Research themes

Contact

Biomedical Center
alej Svobody 1655/76
323 00 Plzeň – Severní Předměstí

or

Oddělení toxikogenomiky
Centrum toxikologie a zdravotní bezpečnosti
Státní zdravotní ústav
Šrobárova 48
100 42 Praha 10
E: This email address is being protected from spambots. You need JavaScript enabled to view it.
T: +420 267 082 711

Members

  • Assoc. Prof. Pavel Souček, Ph.D., M.Sc. – Research Group Leader
  • Pavel Dvořák, M.Sc., Ph.D.
  • Veronika Brynychová, M.Sc.
  • Marie Ehrlichová, M.Sc.
  • Kateřina Elsnerová, M.Sc.
  • Viktor Hlaváč, M.Sc.
  • Tereza Kunická, M.Sc.
  • Simona Šůsová, M.Sc.

Publications – Projects – Cooperation

News

Contact

Charles Univerzity
Faculty of Medicine in Pilsen
Biomedical Center

alej Svobody 1655/76
323 00 Plzeň – Severní Předměstí

T: +420 377 593 810
E: This email address is being protected from spambots. You need JavaScript enabled to view it.

Login

Log in to your account or Create an account